Free Trial

Vident Advisory LLC Buys New Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Vident Advisory LLC acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 14,405 shares of the health services provider's stock, valued at approximately $1,075,000.

Several other hedge funds and other institutional investors have also made changes to their positions in MMS. UMB Bank n.a. boosted its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the period. V Square Quantitative Management LLC raised its holdings in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after acquiring an additional 180 shares in the last quarter. R Squared Ltd acquired a new stake in Maximus in the fourth quarter valued at approximately $54,000. IFP Advisors Inc raised its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after acquiring an additional 428 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Read Our Latest Research Report on Maximus

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is currently owned by insiders.

Maximus Stock Down 1.1%

MMS stock traded down $0.82 during midday trading on Thursday, reaching $71.82. 61,166 shares of the company were exchanged, compared to its average volume of 605,195. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The stock's 50-day simple moving average is $69.70 and its 200 day simple moving average is $71.94. The company has a market cap of $4.05 billion, a price-to-earnings ratio of 15.44 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $1.57 earnings per share. On average, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.67%. Maximus's dividend payout ratio (DPR) is 23.86%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines